Stella Kamanda
Hematology & Oncology · Little Rock, ARNPI 1164468963
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in AR, where the typical reported total is $4,667.
Across 53 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$133
- Bayer$114
- Eisai Inc.$75
- AstraZeneca$61
- Pfizer$58
- Lilly USA, LLC$49
- plus $391 from 15 others
What the payments were for
- Food & beverage$882100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 9 | $133 |
| Bayer | 6 | $114 |
| Eisai Inc. | 4 | $75 |
| AstraZeneca(2 entities) | 4 | $61 |
| Pfizer | 4 | $58 |
| Lilly USA, LLC | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $43 |
| Incyte Corporation | 2 | $41 |
| Johnson & Johnson | 2 | $36 |
| Exelixis Inc. | 2 | $34 |
| Bristol Myers Squibb | 2 | $31 |
| AbbVie | 2 | $29 |
| Secura Bio, Inc. | 1 | $26 |
| GSK | 1 | $24 |
| Foundation Medicine, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Novartis | 1 | $14 |
| Gilead | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$882 in reported general payments places this provider in the 30th percentile of 92 hematology & oncology providers in Arkansas.
Other hematology & oncology in Little Rock
- Frits van RheeLittle Rock$218K
- Appalanaidu SasapuLittle Rock$63K
- Peter EmanuelLittle Rock$53K
- Brad BaltzLittle Rock$25K
- Carolina SchinkeLittle Rock$23K
- Pooja MotwaniLittle Rock$21K
- Naveen YarlagaddaLittle Rock$18K
- Joseph BeckLittle Rock$16K
- Konstantinos ArnaoutakisLittle Rock$12K
- Abhijit GodboleLittle Rock$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.